Max Healthcare Institute (MAXHEALTH) — Corporate Action

Max Healthcare Institute reported FY2025 revenue of ₹7,02,846 lakhs and net profit of ₹1,07,588 lakhs, up sharply from prior periods, with EPS of ₹11.07. The Board recommended a final dividend of ₹1.50 per share (15% of face value), subject to shareholder approval at the upcoming AGM, and plans to expand bed capacity at its Nagpur hospital by ~100 beds over 30 months at a cost of ₹118 crores, funded through internal accruals and a ₹100 crore term loan from Axis Bank. Statutory auditor S.R. Batliboi & Co. LLP was appointed for a 5-year term starting FY2025-26, alongside re-appointments of cost and secretarial auditors. The company also divested equity in Sandhya Hydro Power Projects for ₹1,28,43,960 and continued its Non-Executive Director until AGM approval despite age considerations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MAXHEALTH ✨ Ask AI About This

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

💡 Ask AI about this filing

"How does this corporate action affect Max Healthcare Institute Limited's outlook?" "What did Max Healthcare Institute Limited announce on 20 May 2025?" "Is this positive or negative for MAXHEALTH?"

Ask AI Free →

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

🔥 Also filed on 20 May 2025

TORNTPHARM Torrent Pharmaceuticals Limited Corporate Action SRF SRF Limited Financial Results SIEMENS Siemens Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Corporate Action TORNTPHARM Torrent Pharmaceuticals Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.